MSB 2.23% $1.10 mesoblast limited

I am confused about the discussion of Warren buffet and...

  1. 1,981 Posts.
    lightbulb Created with Sketch. 434
    I am confused about the discussion of Warren buffet and Biotech......lol.....

    Biogen is an established biotech with $15b in revenue and established years ago and have history, drugs (they can actually sell in the market and get revenue) and a good pipleline...and another game changer potential of AZ (high risk high reward)

    Comparing that to MSB is crazy....and please don't mind a bit dumb...

    There are early stage/pre revenue Biotechs (Like MSB and others) which I think what EML333 was referring to when he referred to Warren B and than we have multibillion revenue biotech's (like Biogen)...

    I know for some people this is a given knowledge but judging by some of the comments in previous threads won't be surprised if that isn't the case
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.10
Change
-0.025(2.23%)
Mkt cap ! $1.250B
Open High Low Value Volume
$1.13 $1.16 $1.04 $14.57M 13.49M

Buyers (Bids)

No. Vol. Price($)
4 21024 $1.09
 

Sellers (Offers)

Price($) Vol. No.
$1.10 241 1
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.